Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Oncogene
|
December 22, 2018
Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis
Katrin Tiemann, Carolina Garri, Sang Bok Lee, et al.
Oncotarget
|
June 26, 2018
Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2)
Carolina Garri, Shannon Howell, Katrin Tiemann, et al.
Molecular Cancer Therapeutics
|
June 2, 2017
JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
Kian Kani, Carolina Garri, Katrin Tiemann, et al.
British Journal of Haematology
|
December 8, 2025
Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine
Sandra Ortega-Francisco, Maria Teresa Prudente de Aquino, Corinna La Rosa, et al.
Transplantation and Cellular Therapy
|
August 9, 2024
Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation
Shukaib Arslan, Amrita Desai, Dongyun Yang, et al.
Transplantation and Cellular Therapy
|
July 5, 2025
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal Impairment
Tina Nguyen, Tanya Markary, Ni-Chun Tsai, et al.
Frontiers in Immunology
|
March 7, 2025
Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis
Diana T Samuels, Janny M Yao, Yazeed Samara, et al.
The Lancet. Microbe
|
March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial
Flavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Oncogene
|
December 22, 2018
Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis
Katrin Tiemann, Carolina Garri, Sang Bok Lee, et al.
Oncotarget
|
June 26, 2018
Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2)
Carolina Garri, Shannon Howell, Katrin Tiemann, et al.
Molecular Cancer Therapeutics
|
June 2, 2017
JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
Kian Kani, Carolina Garri, Katrin Tiemann, et al.
British Journal of Haematology
|
December 8, 2025
Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine
Sandra Ortega-Francisco, Maria Teresa Prudente de Aquino, Corinna La Rosa, et al.
Transplantation and Cellular Therapy
|
August 9, 2024
Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation
Shukaib Arslan, Amrita Desai, Dongyun Yang, et al.
Transplantation and Cellular Therapy
|
July 5, 2025
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal Impairment
Tina Nguyen, Tanya Markary, Ni-Chun Tsai, et al.
Frontiers in Immunology
|
March 7, 2025
Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis
Diana T Samuels, Janny M Yao, Yazeed Samara, et al.
The Lancet. Microbe
|
March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial
Flavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Page
of 2